iNOS inhibitor treatment significantly impairs the clearance of B. mallei infection and iNOS deficient mice succumb to B. mallei infection 30 days post-infection (Brett et al., 2008; Rowland et al., 2010). The gene discussed is NOS2; the disease is infection.